The Weekly Litigation News Digest is now live. Subscribe now

Concert Pharmaceuticals competitive analysis

Loading summary...

Explore patent oppositions filed by Concert Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods For Treating Hair Loss DisordersTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKApr 30, 2020
Pyrrolo[2,3-D]Pyrimidine Derivatives As Janus Kinase InhibitorINCYTEJun 28, 2019

Explore Concert Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Feb 24, 2021Deuterated Derivatives Of Ruxolitinib1

Latest PTAB cases involving Concert Pharmaceuticals

Discover the latest PTAB cases involving Concert Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Concert Pharmaceuticals

PGR2021-00006Oct 28, 2020INCYTECONCERT PHARMACEUTICALSFinal Written Decision
PGR2017-00034Jun 27, 2017CONCERT PHARMACEUTICALSINCYTEInstitution Denied
IPR2017-01256Apr 7, 2017INCYTECONCERT PHARMACEUTICALSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Concert Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CONCERT PHARMACEUTICALS2112
INCYTE11321
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - 5 - 21